TRIMEBUTINE BASE

Trimebutine base modulates GI motility through opioid receptor activity, used for IBS and abdominal pain. Side effects include dry mouth, dizziness, nausea, and mild sedation. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 061d56f70d38 Category: Tag:

Product Description


Mechanism of Action

TRIMEBUTINE BASE demonstrates multilayer biochemical influence across signalling hierarchies, catalyticdomain regulation, mitochondrialnetwork energetics, iongradient stability, membrane electrochemistry, redox equilibrium and transcriptionfactor axis alignment. Its molecular topology enables interaction with catalytic residues, allosteric nodes, hydrophobic receptor microdomains, transmembrane helices, redoxbuffer matrices and cytoskeletal scaffolds, resulting in widespectrum modulation across metabolic, structural, electrophysiological and genomic systems.

Mechanistically, TRIMEBUTINE BASE may remodel phosphorylation flux across MAPK/ERK/JNK/p38 pathways, reshape PI3KAKT survival topology, modify Gprotein coupling dynamics, reorganise Ca²⁺ signalling microdomains, influence IP/DAG cascade geometry and adjust cAMPPKA amplitude distributions. Mitochondrial impacts include ETCcomplex rebalancing, ATP/ADP turnover pattern shifts, ROSthreshold displacement, membranepotential polarity modulation and ERmitochondrial stresscrosstalk regulation.

Advanced

  • Kinomescale interference mapping and catalyticcascade simulation
  • Highresolution docking and conformationaltransition modelling
  • UPR/ERstress, autophagymitophagy and organellenetwork integration research
  • Multiomics regulatory reconstruction (RNAseq, phosphoproteomics, metabolomics, proteomics)
  • Cytoskeletal tensionmapping and polymerturnover analysis
  • Cellfate simulations (apoptosis, necroptosis, ferroptosis, parthanatos)
  • Machinelearning SAR/QSAR predictive optimisation

Toxicodynamics & Hazard Profile

  • Accelerated ROS accumulation & antioxidantbuffer saturation
  • Mitochondrial fragmentation or ETCaxis destabilisation
  • Severe Na⁺/K⁺/Ca²⁺ ionic-flux dysregulation
  • Cytoskeletal collapse & membrane-integrity failure
  • Inflammatoryaxis hyperactivation (NF-κB, STAT, IRF pathways)
  • Activation of multiaxis programmed-cell-death pathways
  • Epigenetic methylation/acetylation drift

For expert laboratory research only not intended for biological or therapeutic exposure.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C22H29NO5

Molecular Weight

387.5 g/mol

CAS Number

39133-31-8

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Insoluble

Purity

Purity information is available upon request (COA).

Synonym

trimebutine; 39133-31-8; 2-(Dimethylamino)-2-phenylbutyl 3,4,5-trimethoxybenzoate; Trimebutina; Trimebutinum

IUPAC/Chemical Name

[2-(dimethylamino)-2-phenylbutyl] 3,4,5-trimethoxybenzoate

InChl Key

LORDFXWUHHSAQU-UHFFFAOYSA-N

InChl Code

InChI=1S/C22H29NO5/c1-7-22(23(2)3,17-11-9-8-10-12-17)15-28-21(24)16-13-18(25-4)20(27-6)19(14-16)26-5/h8-14H,7,15H2,1-6H3

References

https://pubchem.ncbi.nlm.nih.gov/compound/5573;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download